Hyundai Bioscience Co Ltd
KOSDAQ:048410
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hyundai Bioscience Co Ltd
Cash from Financing Activities
Hyundai Bioscience Co Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyundai Bioscience Co Ltd
KOSDAQ:048410
|
Cash from Financing Activities
₩74.4B
|
CAGR 3-Years
254%
|
CAGR 5-Years
18%
|
CAGR 10-Years
23%
|
|
|
AmorePacific Corp
KRX:090430
|
Cash from Financing Activities
-₩222.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-12%
|
|
|
Amorepacific Group
KRX:002790
|
Cash from Financing Activities
-₩247B
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-13%
|
|
|
Cosmax Inc
KRX:192820
|
Cash from Financing Activities
₩28.3B
|
CAGR 3-Years
101%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Cash from Financing Activities
-₩443B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-7%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Cash from Financing Activities
₩40.2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hyundai Bioscience Co Ltd
Glance View
HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.
See Also
What is Hyundai Bioscience Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
74.4B
KRW
Based on the financial report for Dec 31, 2025, Hyundai Bioscience Co Ltd's Cash from Financing Activities amounts to 74.4B KRW.
What is Hyundai Bioscience Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
23%
Over the last year, the Cash from Financing Activities growth was 288%. The average annual Cash from Financing Activities growth rates for Hyundai Bioscience Co Ltd have been 254% over the past three years , 18% over the past five years , and 23% over the past ten years .
